MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/europace/euaa171

Медицинская библиотека · Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2020

Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study.

Peretto Giovanni, Barison Andrea, Forleo Cinzia, Di Resta Chiara, Esposito Antonio, Aquaro Giovanni Donato, Scardapane Arnaldo, Palmisano Anna, Emdin Michele, Resta Nicoletta, Santoni Anna, Guaricci Andrea Igoren, Santobuono Vincenzo Ezio, Pepe Martino, Favale Stefano, Ferrari Maurizio, Benedetti Sara, Della Bella Paolo, Sala Simone

СтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

AIMS: We aimed at addressing the role of late gadolinium enhancement (LGE) in arrhythmic risk stratification of LMNA-associated cardiomyopathy (CMP).

METHODS AND

RESULTS

We present data from a multicentre national cohort of patients with LMNA mutations. Of 164 screened cases, we finally enrolled patients with baseline cardiac magnetic resonance (CMR) including LGE sequences [n = 41, age 35 ± 17 years, 51% males, mean left ventricular ejection fraction (LVEF) by echocardiogram 56%]. The primary endpoint of the study was follow-up (FU) occurrence of malignant ventricular arrhythmias [MVA, including sustained ventricular tachycardia (VT), ventricular fibrillation, and appropriate implantable cardioverter-defibrillator (ICD) therapy]. At baseline CMR, 25 subjects (61%) had LGE, with non-ischaemic pattern in all of the cases. Overall, 23 patients (56%) underwent ICD implant. By 10 ± 3 years FU, eight patients (20%) experienced MVA, consisting of appropriate ICD shocks in all of the cases. In particular, the occurrence of MVA in LGE+ vs. LGE- groups was 8/25 vs. 0/16 (P = 0.014). Of note, no significant differences between LGE+ and LGE- patients were found in currently recognized risk factors for sudden cardiac death (male gender, non-missense mutations, baseline LVEF <45% and non-sustained VT), all P-value >0.05.

CONCLUSIONS

In LMNA-CMP patients, LGE at baseline CMR is significantly associated with MVA. In particular, as suggested by this preliminary experience, the absence of LGE allowed to rule-out MVA at 10 years mean FU.

Для цитирования: Peretto Giovanni, Barison Andrea, Forleo Cinzia, Di Resta Chiara, Esposito Antonio, Aquaro Giovanni Donato, Scardapane Arnaldo, Palmisano Anna, Emdin Michele, Resta Nicoletta, Santoni Anna, Guaricci Andrea Igoren, Santobuono Vincenzo Ezio, Pepe Martino, Favale Stefano, Ferrari Maurizio, Benedetti Sara, Della Bella Paolo, Sala Simone. Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2020. DOI: 10.1093/europace/euaa171.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.